bioRxivBiochemistryPreprint
Tryptophan and IFN-γ Differentially Modulate Cellular Uptake, Intracellular Trafficking, and Gene Expression of Messenger RNA-Loaded Lipid Nanoparticles in Dendritic Cells
Zitao MaiD, Reena JatyaniD, Nikki CrowleyiD, Cierra GirardiiD, Mariya KhaniD, Akeile SmithiD, Pu-Sheng WeiiD, Yu-Hsuan TsaiiD, Kuo‐Ching MeiiD
Abstract
Lipid nanoparticle (LNP)-mediated mRNA delivery has emerged as a powerful platform for both immunostimulatory and immunomodulatory applications. However, the influence of local immunometabolic cues on the intracellular fate and translational efficiency of mRNA-LNPs remains poorly understood. In this study, we investigated how interferon-gamma (IFN-{gamma}), a potent inducer of indoleamine 2,3-dioxygenase 1 (IDO1), and tryptophan (Trp) deprivation independently and combinatorially affect mRNA-LNP function in DC2.4 dendritic cells. These two cues are canonical drivers of immunoregulatory microenvironments, particularly those that favor tolerogenic dendritic cell programming and the induction of regulatory T cells. Using dual-reporter mRNA constructs and high-resolution confocal imaging, we show that IFN-{gamma} stimulation reduces total cellular mRNA uptake and lysosomal accumulation without affecting translation efficiency and endosomal escape efficiency. Whereas Trp deprivation also reduces the overall cellular uptake of mRNA-LNPs, it also significantly impairs protein synthesis from mRNA-LNPs and modestly reduces endosomal escape, despite having minimal impact on lysosomal mRNA levels. Spatial compartmentalization analysis revealed that IFN-{gamma} and Trp limitation disrupt distinct steps in the delivery-translation cascade, acting independently but additively to suppress the ultimate protein translation from mRNA-LNPs in DC2.4 dendritic cells. These findings highlight the importance of considering local metabolic and cytokine contexts when deploying mRNA-LNPs for immunological applications. Our work provides mechanistic insights into how immunoregulatory environments impair the delivery and translation of mRNA-LNPs, suggesting strategies to tune delivery outcomes for tolerogenic purposes.
- organism: mouse
- assay: bulk RNA-seq
- research focus: cell signaling & trafficking
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Anionic lipids modulate mRNA-lipid nanoparticle immunogenicity and confer protection in a mouse model of multiple sclerosis
Jilian R. Melamed, Jenna Muscat-Rivera, … Drew Weissman·bioRxiv·Oct 17, 2025
- Synthesis and Assembly of a New-generation Bifunctional Lipid Nanoparticle for Selective Delivery of mRNA to Antigen Presenting Cells
Chen‐Yo Fan, Szu-Wen Wang, Chi‐Huey Wong·bioRxiv·Feb 26, 2026
- Synthesis and Assembly of a New-generation Bifunctional Lipid Nanoparticle for Selective Delivery of mRNA to Antigen Presenting Cells
C.-Y. Chen, S.-W. Wang, C.-H. Wong·bioRxiv·Dec 26, 2023
- Optimization of a liver Trm cell-inducing mRNA vaccine by reduction of type I interferon response
Jordan James Minnell, Mitch Ganley, … Ian F. Hermans·bioRxiv·May 12, 2026
- Lipid nanoparticle shape and morphology determine the magnitude and duration of mRNA transfection
Sara Elsafy, Martin Dulle, … Alexandros Marios Sofias·bioRxiv·Oct 22, 2026
- Systemic trafficking of mRNA lipid nanoparticle vaccine following intramuscular injection generates potent tissue-specific T cell response
Christine Y. Wei, Yining Zhu, … Hai‐Quan Mao·bioRxiv·Apr 21, 2025